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A B S T R A C T
Background: Inorganic nitrite has shown beneﬁcial eﬀects in cardiovascular and metabolic diseases partly via
attenuation of NADPH-oxidase (NOX)-mediated oxidative stress. However, the exact mechanisms are still
unclear. Here we investigated the role of S-nitrosation or altered expression of NOX subunits, and the role of
xanthine oxidoreductase (XOR) in nitrite-derived nitric oxide (NO) production.
Methods: Mouse macrophages were activated with LPS in the presence or absence of nitrite. NOX activity was
measured by lucigenin-dependent chemiluminescence. Gene and protein expression of NOX2 subunits and
XOR were investigated using qPCR and Western Blot. S-nitrosation of Nox2 and p22phox was studied with a
Biotin Switch assay. Uric acid levels in cell culture medium were analyzed as a measure of XOR activity, and NO
production was assessed by DAF-FM ﬂuorescence.
Results: NOX activity in activated macrophages was signiﬁcantly reduced by nitrite. Reduced NOX activity was
not attributed to decreased NOX gene expression. However, protein levels of p47phox and p67phox subunits
were reduced by nitrite in activated macrophages. Protein expression of Nox2 and p22phox was not inﬂuenced
by this treatment and neither was their S-nitrosation status. Increased uric acid levels after nitrite and
diminished NO production during XOR-inhibition with febuxostat suggest that XOR is more active during
nitrite-treatment of activated macrophages and plays an important role in the bioactivation of nitrite.
Conclusions: Our ﬁndings contribute to the mechanistic understanding about the therapeutic eﬀects associated
with nitrite supplementation in many diseases. We show that nitrite-mediated inhibition of NOX activity cannot
be explained by S-nitrosation of the NOX enzyme, but that changes in NOX2 expression and XOR function may
contribute.
1. Introduction
Immune cells, like macrophages, are major sources of reactive
oxygen species (ROS) in the body. Particularly superoxide is produced
by NADPH oxidase (NOX), an enzyme family consisting of several
isoforms of which NOX2 is the main isoform expressed in macrophages
and neutrophils. The superoxide anion is important for eﬀective host
defense, immune cell function and is a component of the cellular redox
signaling. However, when overproduction of superoxide persists, the
normal redox signaling gets disrupted leading to oxidative stress, in
which an imbalance develops between ROS and nitric oxide (NO).
Oxidative stress represents a major risk factor and cause of both
metabolic and cardiovascular diseases [1]. It can be ameliorated either
by a decrease in ROS production or an increase in NO bioavailability.
In addition to NO production via the classic nitric oxide synthase
(NOS) pathway, fueling the alternative nitrate-nitrite-NO pathway with
inorganic nitrate and nitrite has shown beneﬁcial eﬀects in many
disorders and experimental disease models via restoring NO bioavail-
ability [2–4]. However, it is still not clear how this eﬀect is mediated
and signaling events may occur in a cell-, tissue- and environment-
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speciﬁc manner. In a recent study, we demonstrated that augmented
NOX-mediated ROS production in lipopolysaccharide (LPS)-activated
mouse macrophages was almost normalized by simultaneous nitrite
treatment [5]. This eﬀect of nitrite on superoxide production was
abolished by an NO scavenger and also during inhibition of xanthine
oxidoreductase (XOR), which suggests that nitrite acts via an NO
signaling mechanism that is dependent on functional XOR.
XOR, a molybdoﬂavin-containing enzyme responsible for the
terminal steps of purine catabolism, catalyzes the hydroxylation of
hypoxanthine to xanthine and xanthine to uric acid, which is accom-
panied by ROS production. However, under certain conditions, XOR is
able to use inorganic nitrite as a substrate and generate NO [6,7].
Especially during low oxygen tensions, which occur during ischemia
reperfusion injuries, this way of NO production seems important and
may compensate for a compromised NOS function since this enzyme is
dependent on oxygen. Immune cells like macrophages are present at
sites of tissue injury where they may become lytic and therefore a
signiﬁcant source of XOR.
In addition to activating cGMP-dependent signaling pathways NO
can mediate protein S-nitrosation by attachment of an NO+ moiety to
cysteine residues in proteins. This S-nitrosothiol formation may
inﬂuence protein function and has been widely recognized as a
signaling mechanism [8,9]. There is emerging evidence that protein
S-nitrosation may be altered during disease development, and hence
play a role in renal and cardiac protection [10] as well as in modulation
of the immune system [11]. The reaction is highly regulated and
exhibits remarkable speciﬁcity occurring only on selected cysteine
residues located within a certain amino acid motif and basic surround-
ing conditions [12].
In the current study we used murine macrophages to investigate if
the previously demonstrated eﬀects of inorganic nitrite on oxidative
stress are achieved via XOR-dependent NO production and if NO-
mediated S-nitrosation of NOX subunits may contribute to the reduced
NOX activity following treatment with inorganic nitrite.
2. Material and methods
2.1. Materials
Unless otherwise indicated all chemicals were purchased from
Sigma-Aldrich (Stockholm, Sweden).
2.2. Cell culture
Mouse peritoneal macrophages (IC-21 ATCC TIB-186; American
Type Culture Collection, Manassas, VA, USA) were cultured in RPMI
1640 medium complemented with 10% fetal bovine serum, 2 mmol/l L-
glutamine, 100 units/ml penicillin, and 100 µg/ml streptomycin (all
Thermo Fisher Scientiﬁc, Stockholm, Sweden) and in humidiﬁed air
with 5% CO2 at 37 °C. Medium was replaced every other day and cells
were passaged using Dulbecco's phosphate-buﬀered saline (DPBS,
without Ca2+/Mg2+) when reaching 80–90% conﬂuency. For experi-
ments, macrophages were seeded in plates at a density of 500000 cells/
ml and allowed to attach overnight.
2.3. Pharmacological treatments
Pharmacological treatments of macrophages were performed in
RPMI medium without fetal bovine serum. After the normal growth
medium was removed, cells were washed once with DPBS.
Macrophages were then incubated with sodium nitrite (NaNO2,
10 µmol/l), LPS from Escherichia coli endotoxin (0111:B4, 10 ng/
ml), diethylenetriamine/NO adduct (DETA-NONOate, 0.5 mmol/l),
Nω-nitro-L-arginine methylester hydrochloride (L-NAME, 1 mmol/l),
febuxostat (30 nmol/l) or a combination thereof, for 24 h or the
indicated times. L-NAME and febuxostat were added 30 min before
treatment with other substances.
To prepare S-nitrosocysteine (CysNO), 1 vol of 200 mmol/l L-
cysteine (in 1 mol/l HCl) was incubated with 1 vol of 200 mol/l sodium
nitrite (in distilled water) for 30 min at room temperature in the dark.
The solution was neutralized by the addition of 2 volumes of 1 mol/l
K2HPO4 (pH 7.4) buﬀer and was stored in aliquots at −80 °C until use.
The concentration of formed CysNO was determined from the optical
absorbance at 338 nm by using the extinction coeﬃcient 900/
(mol*l*cm) [13]. After LPS-treatment or incubation in serum-free
medium for 24 h, macrophages were washed twice with phosphate
buﬀered saline (PBS, containing Ca2+/Mg2+) followed by incubation
with CysNO in PBS for 15 min at 37 °C. Subsequently, cells were
washed with PBS twice and collected for Biotin Switch assay (see
below).
2.4. NADPH-dependent superoxide production
Lucigenin-dependent chemiluminescence was used to determine
NADPH oxidase activity, measured as NADPH-dependent superoxide
production, as described previously [5]. After pharmacological treat-
ments, macrophages were washed with DPBS and detached from the
culture dish by incubation in DPBS at 37 °C for 15 min. Cell suspen-
sions were transferred to measurement tubes and incubated with dark-
adapted lucigenin (5 µmol/l) at 37 °C for 15 min. Superoxide produc-
tion was started by the injection of the NOX substrate NADPH (100
µmol/l) and the chemiluminescence signal was measured every 3 s for
3 min with an AutoLumat LB953 Multi-Tube Luminometer (Berthold
Technologies, Bad Wildbad, Germany). Previous studies have demon-
strated that incubation with either tempol to scavenge superoxide or
VAS3947 to inhibit NOX reduces the chemiluminescence signal with
approximately 90% in both cell culture and tissues [14,15], suggesting
that mainly superoxide from NOX is measured. Moreover, unspeciﬁc
lucigenin-mediated superoxide generation in the absence of added
NADPH was similar to the blank (i.e. PBS only), and should therefore
not have any signiﬁcant impact on the results.
2.5. Biotin Switch assay
Protein S-nitrosation levels were determined in macrophage lysates
using the Biotin Switch assay with some modiﬁcations from the
original protocol [16]. All steps before the neutravidin-puriﬁcation of
biotinylated proteins were carried out in the dark. After treatments,
macrophages were collected and lysed by scraping in TENT buﬀer
(50 mmol/l Tris-HCl pH 7.2, 150 mmol/l NaCl, 1 mmol/l EDTA,
0.1 mmol/l neocuproine, 1% Triton X-100, protease inhibitor cocktail)
and incubation on ice for 15 min. The soluble fraction was obtained by
centrifugation at 10000 g and 4 °C for 15 min. Protein concentration
was determined using the Bradford protein assay (Bio-Rad) and
samples were adjusted to 0.5 mg/ml with TEN buﬀer (TENT without
Triton X-100). Free thiols were blocked in 4 volumes of HENS buﬀer
(250 mmol/l Hepes pH 7.7, 1 mmol/l EDTA, 0.1 mmol/l neocuproine,
1% SDS) containing 20 mmol/l S-methyl methanethiosulfonate at
50 °C for 30 min with agitation every 5 min. Proteins were precipitated
with cold acetone for at least 30 min at −20 °C to remove excess
blocking reagent. To reduce SNO-thiols and label resulting SH-
residues, precipitated proteins were resuspended in 300 µl HENS/mg
protein containing 5 mmol/l ascorbate and incubated in the presence
of 1 mmol/l (N-[6-(Biotinamido)hexyl]-3′-(2′-pyridyldithio)propiona-
mide (HPDP-biotin, Thermo Fisher Scientiﬁc) for 2 h at room tem-
perature. After aceton precipitation, biotinylated proteins were resus-
pended in 150 µl HENS/mg protein and puriﬁed by incubation with
NeutrAvidin Plus Ultra Link Resin (Thermo Fisher Scientiﬁc) in 5
volumes neutralization buﬀer (20 mmol/l Hepes pH 7.7, 100 mmol/l
NaCl, 1 mmol/l EDTA, 0.5% Triton X-100) over night at 4 °C. Bound
proteins were washed extensively (20 mmol/l Hepes pH 7.7, 600 mmol
NaCl, 1 mmol/l EDTA, 0.5% Triton X-100), eluted from the resin at
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37 °C for 20 min with 1 mmol/l β-mercaptoethanol in 20 mmol/l
Hepes pH 7.7, 100 mmol/l NaCl, 1 mmol/l EDTA, and analyzed using
Western Blot.
2.6. Real-time PCR
The mRNA expression levels of NOX subunits and xanthine oxidase
(XOR) were determined by real-time PCR. After treatments, macro-
phages were collected in β-mercaptoethanol containing RLT buﬀer and
total RNA was isolated using the RNeasy Mini Kit (Qiagen, Sollentuna,
Sweden) according to the manufacturer's instructions. RNA purity and
concentration were assessed spectrophotometrically on the Nanodrop
ND-1000 (Thermo Fisher Scientiﬁc). Equal amounts of RNA were
reverse transcribed to cDNA with the High Capacity cDNA Reverse
Transcription Kit (Thermo Fisher Scientiﬁc). Real-time PCR was
performed in 96-well plates in a total reaction volume of 20 µl on an
ABI 7500 Real-Time PCR System using Power SYBR Green Master mix
(Thermo Fisher Scientiﬁc) and gene speciﬁc primers (Table 1). Mean x-
fold relative gene expression changes were calculated with the ΔΔCt-
method [17], standardizing the results to the housekeeping gene β-
actin.
2.7. Western Blot
Protein fractions from the Biotin Switch assay (input and eluted
proteins) were denaturated in loading buﬀer (62.5 mmol/l Tris-HCl pH
6.8, 10% glycerol, 2% sodium dodecyl sulfate (SDS), 0.01% bromo-
phenol blue, 0.8% β-mercaptoethanol) at 95 °C for 5 min. Protein
expression of NOX subunits was measured by Western Blot in
macrophages. Whole cell lysates were prepared by scraping the cells
in lysis buﬀer (10 mmol/l Tris-HCl pH 8, 150 mmol/l NaCl, 5 mmol/l
EDTA, 60 mmol/l N-octyl-glucoside, 1% Triton X-100, protease in-
hibitor cocktail) followed by centrifugation at 10000 g for 15 min.
Protein concentration was determined in the soluble fraction using the
Bradford protein assay (Bio-Rad, Solna, Sweden) and equal amounts of
protein were denaturated in loading buﬀer at 95 °C for 5 min. Proteins
were separated on 4–20% SDS-polyacrylamide gels (Bio-Rad) using
electrophoresis and transferred to polyvinylidene diﬂuoride mem-
branes (Bio-Rad). The membranes were blocked in 5% nonfat dry milk
containing TBS-T (20 mmol/l Trizma base pH 7.6, 150 mmol/l NaCl,
0.1% Tween-20), followed by incubation with primary antibodies
(gp91phox/Nox2, BD Biosciences, Stockholm, Sweden; p67phox, Cell
Signaling/BioNordika, Stockholm, Sweden; p22phox, p47phox and
XOR, Santa Cruz, Heidelberg, Germany). Primary antibodies were
detected using the respective horseradish peroxidase-conjugated goat
anti-rabbit or anti-mouse IgG (Cell Signaling). Protein bands were
visualized by Clarity Western ECL Substrate (Bio-Rad) and intensities
were quantiﬁed using densitometry (Image Lab software, Bio-Rad). To
ensure equal protein loading, membranes were stripped using
Restore™ PLUS Western Blot Stripping Buﬀer (Thermo Fisher
Scientiﬁc) and after blocking re-probed with primary antibody against
β-actin (Santa Cruz) and anti-mouse IgG. Mean x-fold relative protein
expression changes were calculated by standardizing the results to the
housekeeping protein β-actin. For the comparison of S-nitrosated
proteins between LPS- and LPS+CysNO treated cells, the relative
intensity ratio SNO-protein/input was calculated for Nox2 and
p22phox, respectively, and is presented in the text (LPS treated
groups=1). Since the LPS-treatment strongly aﬀected the expression
of the studied proteins and SNO-signals were often weak, quantiﬁca-
tion of SNO-protein/input seemed arbitrary and was omitted for other
between-group comparisons but representative blots are shown in-
stead.
2.8. Uric acid assay
Uric acid is the ﬁnal oxidation end product of purine nucleotide
metabolism catalyzed by XOR from xanthine and hypoxanthine. Uric
acid levels were measured in macrophage cell culture medium after
24 h treatments as a measure of XOR activity. Samples were incubated
with 80 µmol/l Amplex Ultra Red reagent (Thermo Fisher Scientiﬁc),
0.8 U/ml horse radish peroxidase and 2 U/ml uricase in 100 mmol/l
Tris-HCl pH 7.5 for 30 min at 37 °C. The ﬂuorescence signal was
measured in a microplate reader (excitation 530 nm, emission 590 nm)
and the concentration of uric acid was calculated from a standard curve
on the same plate. To investigate how much of the uric acid is derived
from XOR, uric acid levels in culture medium of febuxostat (30 nmol/l)
treated macrophages were measured with the same approach. As a
control, 2.5 mU/ml puriﬁed XOR enzyme was used in a cell-free
approach and incubated for 30 min at 37 °C with 32 µmol/l hypox-
anthine (Sigma), 80 µmol/l Amplex Ultra Red reagent (Thermo Fisher
Scientiﬁc), 0.8 U/ml horse radish peroxidase in 100 mmol/l Tris-HCl
pH 7.5 with or without 2 U/ml uricase and in the presence of diﬀerent
febuxostat concentrations (3, 30, 300, 3000 nmol/l). The ﬂuorescence
signal was measured in a microplate reader (excitation 530 nm,
emission 590 nm) and the signal without uricase (representing H2O2
production) was subtracted from the signal with uricase (resulting in
only uric acid-derived ﬂuorescence signal). Results are presented as %
inhibition with febuxostat vs. no febuxostat.
2.9. DAF-FM ﬂuorescence
The cell-permeable ﬂuorescent NO indicator 4,5-diaminoﬂuores-
cein-FM diacetate (DAF-FM DA) was used to detect NO production in
macrophages. The cells were plated and treated in 96-well plates as
described above. After 24 h, the cells were loaded with DAF-FM DA
(10 µM) for 45 min at 37 °C. Cells were then washed with DPBS and
transferred to a black 96-well plate. The ﬂuorescence signal was
measured in a microplate reader (excitation 495 nm, emission
515 nm) and is expressed as the percentage change of the L-NAME
treated cells.
2.10. Statistical analysis
Results are expressed as means ± SEM. Statistical analyses were
performed using one-way ANOVA followed by Bonferroni's multiple
comparison test (GraphPad Prism version 5.04, San Diego, CA, USA). A
p-value < 0.05 was considered statistically signiﬁcant.
Table 1
Nucleotide-sequences of primers used in real-time PCR.
Gene Forward primer (5′−3′) Reverse primer (5′−3′)
Nox2 GCACCTGCAGCCTGCCTGAATT TTGTGTGGATGGCGGTGTGCA
p22phox CTGGCGTCTGGCCTGATTCTCATC CCGAAAAGCTTCACCACAGAGGTCA
p47phox CAGCCATGGGGGACACCTTCATT GCCTCAATGGGGAACATCTCCTTCA
p67phox AAGACCTTAAAGAGGCCTTGACGCA TCGGACTTCATGTTGGTTGCCAA
XOR CAGCATCCCCATTGAGTTCA GCATAGATGGCCCTCTTGTTG
β-actin GCTCCTCCTGAGCGCAAT GTGGACAGTGAGGCCAGGAT
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3. Results
3.1. Nitrite reduces superoxide generation in LPS-activated
macrophage
As has been shown recently [5], 24 h activation of macrophages
with LPS resulted in increased NADPH-dependent superoxide produc-
tion and this was attenuated by simultaneous incubation with nitrite.
To mimic a more therapeutic situation with administration of nitrite
during ongoing inﬂammation, macrophages were incubated with LPS
for 21 h, then nitrite was added and the cells were incubated for
another 3 h. This short time was suﬃcient for a signiﬁcant reduction of
the superoxide generation even though LPS was still present (Fig. 1). In
control cells, nitrite had no eﬀect on superoxide production indepen-
dently of the incubation time.
3.2. Nitrite does not alter the gene expression of NOX2 subunits
One possible mechanism how nitrite might mediate this attenua-
tion of NOX-derived superoxide formation is through changes in
enzyme expression. Therefore, we investigated gene expression levels
of the NOX2 subunits in activated and nonactivated macrophages.
Treatment with LPS resulted in a strong induction of Nox2, however
p47phox was unchanged and levels of p22phox and p67phox were even
decreased. Nitrite had no eﬀect in nonactivated cells and did not alter
the expression levels of any of the analyzed subunits when adminis-
tered together with LPS compared to LPS alone (Fig. 2A–D).
3.3. Nitrite modulates protein expression of NOX2 subunits in LPS-
activated macrophages
Since mRNA levels do not always reﬂect the abundance of protein
in the cells, we also analyzed the protein expression of NOX2 subunits
in activated and nonactivated macrophages. Stimulation of the cells
with LPS led to a signiﬁcant increase of Nox2, p22phox, p47phox and
p67phox. Whereas the levels of the membrane bound subunits Nox2
and p22phox were not inﬂuenced by the presence of nitrite (Fig. 3A,B),
the expression of the cytosolic subunits p47phox and p67phox was
signiﬁcantly reduced in cells treated with LPS plus nitrite compared
with LPS alone (Fig. 3C,D).
3.4. Nitrite does not mediate S-nitrosation of NOX2 subunits
S-nitrosation of cysteine residues has been described as a post-
translational modiﬁcation which impacts on the activity of many
proteins. We therefore investigated if nitrite-derived NO mediates S-
nitrosation of the membrane bound NOX2 subunits and thereby
contributes to the reduced activity of NOX in LPS-activated macro-
phages. In cells treated with LPS, a proportion of both Nox2 and
p22phox underwent S-nitrosation (relative intensity ratio SNO-pro-
tein/input 1 for NOX2 and 1 for p22phox; see methods for details);
however, simultaneous incubation with nitrite for 24 h did not increase
this proportion (relative intensity ratio SNO-protein/input 0.9 for
Nox2 and 0.9 for p22phox). In contrast, a short incubation (15 min)
with the NO-donor CysNO resulted in clear S-nitrosation of both Nox2
and p22phox (relative intensity ratio SNO-protein/input 3.3 for Nox2
and 6.5 for p22phox), which demonstrates that these proteins are able
to undergo S-nitrosation under certain conditions (Fig. 4A). The
mechanisms and kinetics of the release of NO and other reactive
nitrogen species vary between diﬀerent types of NO-donors depending
on their decomposition and the requirement of speciﬁc conditions or
catalysts [18]. Therefore, macrophages were incubated with the slow-
releasing NO-donor DETA-NONOate for 24 h in the presence of LPS,
which resulted in a similar level of S-nitrosation of Nox2 compared to
nitrite, whereas p22hox was not S-nitrosated (Fig. 4B). Especially the
inducible form of endogenous NO synthases (iNOS) produces high
amounts of NO in response to LPS-activation of macrophages. To
exclude the possibility that this large amount of iNOS-derived NO
would mask an eﬀect of nitrite in the detection of S-nitrosation levels,
macrophages were treated with L-NAME to block all NOS isoforms.
However, even during NOS inhibition there were no diﬀerences
between cells treated with LPS alone and LPS plus nitrite (Fig. 4C).
Taken together, these results indicate that the ability of nitrite to
reduce superoxide production during LPS-activation of macrophages is
not mediated by S-nitrosation of Nox2 or p22phox.
3.5. The eﬀects of nitrite are dependent on XOR
We have previously demonstrated that inhibition of XOR abolished
the eﬀect of nitrite on NOX-mediated superoxide production in LPS-
activated macrophages [5]. Since there is evidence implicating XOR in
the reduction of nitrite to NO and other bioactive nitrogen species
[7,19], we investigated the role of this enzyme further by measuring its
gene and protein expression as well as its activity in macrophages.
While mRNA levels of XOR were reduced both upon LPS activation and
LPS plus nitrite treatment, the protein expression was not inﬂuenced
by any of the treatments (Fig. 5A,B). The levels of uric acid were
analyzed in the cell culture medium after 24 h treatment of macro-
phages as a measure of XOR activity. As a control, uric acid production
was measured in the presence of febuxostat and resulted in 50–70%
inhibition both in culture medium of febuxostat treated macrophages
and using puriﬁed XOR enzyme (Supplemental Figure 1). LPS-activa-
tion resulted in an increase in uric acid production compared to
nonactivated cells. Simultaneous treatment with nitrite increased uric
acid levels even further in activated macrophages, which indicates an
induction of XOR activity under these conditions (Fig. 5C). To examine
if this change in XOR activity is relevant for nitrite-derived NO
production, we measured DAF-FM ﬂuorescence, after 24 h treatment
of the macrophages. As shown previously [5], the increased NO
production upon treatment with LPS plus nitrite could not be blocked
by NOS-inhibition with L-NAME. However, additional simultaneous
inhibition of XOR with febuxostat signiﬁcantly reduced the NO
production, resulting in control levels and was similar in all other
groups (Fig. 5D). These results strongly suggest that XOR, not through
changes in its expression but its activity, is involved in the reduction of
nitrite to NO and the subsequent inhibition of NOX-derived superoxide
production in activated macrophages.
Fig. 1. NADPH-dependent superoxide production. NADPH-oxidase-derived superoxide
production is presented as % chemiluminescence (CL) signal/min of the nonactivated
control macrophages. Data are shown as mean ± SEM, n=4–8/group, * p < 0.05 between
indicated groups.
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4. Discussion
We demonstrate here that nitrite-mediated attenuation of NOX-
derived superoxide production in LPS-activated macrophages is asso-
ciated with XOR-dependent NO production. Furthermore, we found
that nitrite-mediated reduction of superoxide production does not
involve S-nitrosation of the membrane-bound NOX subunits Nox2 and
p22phox, but can partially be attributed to changes in protein expres-
sion of the cytosolic subunits p47phox and p67phox.
According to current knowledge, phagocytic NADPH oxidase
NOX2, which is the main isoform expressed in macrophages, consists
of two membrane bound subunits Nox2 (or gp91phox) and p22phox,
the cytosolic subunits p47phox, p67phox, p40phox and a small GTPase
Rac. The assembly process of the active enzyme complex has been
described in detail [20]. Brieﬂy, upon stimulation, p47phox is phos-
phorylated and translocates, in complex with p67phox and p40phox, to
the cell membrane where the active enzyme complex is formed. This
results in a burst of superoxide production. Looking at the gene
expression of NOX subunits we found a strong induction only of
Nox2 mRNA in LPS-activated macrophages. In contrast, the protein
levels of all four investigated subunits were signiﬁcantly increased after
LPS stimulation. Interestingly, the simultaneous treatment with nitrite
only showed an eﬀect on protein expression and reduced levels of
p47phox and p67phox, but not Nox2 and p22phox. If this extent of
protein reduction has suﬃcient impact on the enzyme activity to
explain the reduced superoxide production seen with nitrite in LPS-
activated macrophages is unclear. In addition to expression levels, also
the intracellular distribution of these subunits plays an important role
for NOX activity and might be altered by nitrite. However, it has been
shown in human neutrophils that only 10–15% of p47phox (in complex
with p67phox) translocates to the membrane upon cell activation
[21,22]. Future studies are warranted to investigate if nitrite may
inﬂuence these translocation processes, and hence contribute to the
reduced NOX activity.
Supplementation with both inorganic nitrate and nitrite have
shown beneﬁcial eﬀects in various diseases and experimental models,
e.g. reduced blood pressure in healthy volunteers [23] and in hyper-
tensive patients [24,25] and rats [26], reversed features of metabolic
syndrome [27] and improved glucose and insulin homeostasis in type 2
diabetes and its complications [28,29]. In many cases, the protective
eﬀects of nitrate and nitrite could be linked to reduced NOX-derived
oxidative stress [29–31]. In the current study, we show a therapeutic
eﬀect with nitrite, i.e. administration after 21 h LPS challenge resulted
in reduced NOX activity and prevention of oxidative stress. Also in vivo
nitrite has shown protective eﬀects not only against LPS- but also
against tumor necrosis factor-induced shock in mice [32], however, the
eﬀects on NOX were not addressed in that study.
Since nitrite abolished superoxide production by NOX in an NO-
dependent manner [5], signaling via NO became of particular interest.
There are three principal pathways of physiological NO signaling [33]
including the reaction of NO with thiyl radicals to form S-nitrosothiols.
S-nitrosation has gained increased recognition as a functionally
important posttranslational modiﬁcation and might provide protection
by preventing irreversible oxidative thiol-modiﬁcations by ROS or
peroxynitrite [34]. This action suggests a potential for nitrite-derived
NO to S-nitrosate NOX subunits. Most studies of proteins that have
been identiﬁed as substrates for S-nitrosation used greatly simpliﬁed in
vitro preparations and/or relied on exogenous NO donors rather than
Fig. 2. Gene expression of NOX subunits. Relative mRNA levels for the NOX2 subunits Nox2, p22phox, p47phox and p67phox are presented as fold change of the nonactivated control
macrophages for each gene. Data are shown as mean ± SEM, n=6/group, * p < 0.05 between indicated groups.
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Fig. 3. Protein expression of NOX subunits. Relative protein levels for the NOX2 subunits Nox2, p22phox, p47phox and p67phox are presented as fold change of the nonactivated
control macrophages for each protein. Data are shown as mean ± SEM, n=8/group, * p < 0.05 between indicated groups.
Fig. 4. S-nitrosation of NOX subunits. S-nitrosated proteins (SNO) and the input of Nox2 and p22phox are shown. S-nitrosation was analyzed after cell treatment with LPS, LPS plus
nitrite and either a quick-releasing NO donor (A), a slow-releasing NO-donor (B) or NOS-inhibition (C). Representative results from independent experiments are shown.
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physiological NO produced by endogenous enzymes. We support here
the discrepancy between such conditions since we found that in our
experimental conditions nitrite-derived NO did not mediate S-nitrosa-
tion of Nox2 and p22phox to a greater extent than incubation of
macrophages with LPS alone. However, the presence of the NO donor
CysNO resulted in strong S-nitrosation of both proteins. These results
indicate that nitrite does not reduce LPS-induced superoxide produc-
tion in these cells via functional NO-mediated modulation of the
membrane-bound NOX subunits. However, non-physiologically high
NO concentrations resulted in S-nitrosation of both Nox2 and
p22phox. There are studies suggesting S-nitrosation of NOX isoforms
and subunits, but in these studies puriﬁed proteins and/or NO donors
were used [35,36] and the physiological relevance remains to be
proven. The activity of Nox5, an isoform only expressed in humans,
has been shown to be reduced via NO-mediated S-nitrosation in
transfected COS-7 cells and four cysteine residues have been identiﬁed
as targets for S-nitrosation [37]. This could be of particular interest for
the favorable eﬀects observed with nitrite in humans and future studies
investigating the signaling mechanism in humans are warranted.
XOR has been described as damaging during disease conditions like
ischemia reperfusion injury or atherosclerotic plaques due to its
enhanced aﬃnity for oxygen and concomitant ROS production when
performing its generally accepted role in purine catabolism [38,39]. In
addition, the detailed mechanism has been elucidated how XOR can
also catalyze the reduction of nitrite to NO using either NADH or
xanthine as reducing substrate [40,41]. Especially during conditions
with low oxygen tension, XOR-mediated NO production is fairly high
and can compensate for impaired NOS-derived, oxygen-dependent NO
synthesis [4]. Also in normoxia XOR has been found to produce NO
when nitrite is present as substrate [5,7,42]. Nitrite-mediated attenua-
tion of superoxide production in LPS-activated macrophages has been
described as XOR-dependent since the eﬀect was abolished in the
presence of the XOR inhibitor febuxostat [5]. In this study, we
demonstrate that also the NO production in LPS-activated macro-
phages was dependent on XOR and could be blocked by febuxostat
whereas this eﬀect was independent of NOS. We found increased uric
acid levels in the cell culture medium, which reﬂect increased XOR
activity and are in agreement with previous ﬁndings showing increased
XOR activity in human macrophages upon LPS-stimulation [43]. In
contrast to other tissue and cell types [44,45] gene expression of XOR
was not increased upon inﬂammatory stimulation. In the current study
we show that protein levels of XOR were not inﬂuenced by any of the
treatments and the gene expression was even decreased during
treatment with LPS and LPS plus nitrite, compared to the observed
induction of NOX expression. Therefore we conclude that the elevated
XOR activity does not contribute to the observed superoxide levels, but
rather that NOX is the main source. On the contrary, the increased uric
acid formation might reﬂect increased nitrite reductase activity of XOR,
which leads to increased NO bioavailability and subsequently reduced
NOX-derived superoxide. Still, it is unclear how nitrite-derived NO and
Fig. 5. Role of XOR in the eﬀects mediated by nitrite. Relative mRNA (A) and protein levels (B) of XOR are presented as fold change of nonactivated control macrophages. Uric acid
concentration in macrophage culture medium as a measure of XOR activity is given in µmol/l (C). NO production was measured as DAF-FM ﬂuorescence and is presented as % of the L-
NAME treated macrophages. Data are shown as mean ± SEM, n=6/group (A,C), n=4/group (B), n=8/group (D), * p < 0.05 between indicated groups.
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the reduced NOX activity are connected. Direct scavenging of ROS by
NO [5] as well as enzyme modiﬁcation via S-nitrosation, as shown here,
seem unlikely.
In conclusion, we show in LPS-activated macrophages that XOR
plays an important role in nitrite reduction to NO, leading to decreased
NOX-derived superoxide generation. Reduced NOX activity is however
not mediated by any signiﬁcant NO-dependent S-nitrosation of the
membrane-bound NOX subunits Nox2 or p22phox. Instead, our
ﬁndings suggest that a reduced protein expression of the cytosolic
NOX subunits may contribute to the favorable eﬀect of nitrite. These
mechanistic details are important to further characterize inorganic
nitrate and nitrite as potential therapeutics in ROS-mediated cardio-
vascular and metabolic diseases.
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